RECORNEA Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$15M
- Investors
-
12
RECORNEA General Information
Description
Developer of a corneal medical device designed to restore the physiological curvature of the cornea with clear and predictable clinical outcomes. The company's device utilizes an implantable medical technology capable of improving the vision of patients suffering from keratoconus, enabling healthcare professionals to treat their patients with various pathological conditions that cause deformation of the cornea.
Contact Information
Website
www.recornea.comCorporate Office
- Via della Ginnastica 9
- 34125 Trieste
- Italy
Corporate Office
- Via della Ginnastica 9
- 34125 Trieste
- Italy
RECORNEA Timeline
RECORNEA Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Later Stage VC (Series A) | 18-Nov-2024 | $15M | Completed | Clinical Trials - Phase 1 | ||
| 11. Later Stage VC | 15-Mar-2025 | Completed | Clinical Trials - Phase 1 | |||
| 10. Accelerator/Incubator | 26-Sep-2024 | Completed | Clinical Trials - Phase 1 | |||
| 9. Accelerator/Incubator | 25-Oct-2022 | Completed | Clinical Trials - Phase 1 | |||
| 8. Early Stage VC (Series B) | 17-Jan-2022 | Completed | Clinical Trials - Phase 1 | |||
| 7. Accelerator/Incubator | 12-Oct-2020 | Completed | Clinical Trials - Phase 1 | |||
| 6. Accelerator/Incubator | 01-Jun-2020 | Completed | Clinical Trials - Phase 1 | |||
| 5. Early Stage VC (Series A) | 12-May-2020 | Completed | Clinical Trials - Phase 1 | |||
| 4. Accelerator/Incubator | 01-Feb-2020 | $100K | $330K | Completed | Clinical Trials - Phase 1 | |
| 3. Seed Round | $123K | $230K | Completed | Clinical Trials - Phase 1 |
RECORNEA Patents
RECORNEA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4665271-A1 | Corneal implant | Pending | 13-Feb-2023 | ||
| US-20260224349-A1 | Corneal implant | Pending | 13-Feb-2023 | ||
| WO-2024170950-A8 | Corneal implant | Inactive | 13-Feb-2023 | ||
| EP-3801386-A1 | Corneal implant | Active | 08-Jun-2018 | ||
| EP-3801386-B1 | Corneal implant | Active | 08-Jun-2018 | A61F2/14 |
RECORNEA Signals
RECORNEA Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Caique Holding | Corporation | Minority | ||
| DN Lemans | Corporation | Minority | ||
| Scientifica | Venture Capital | Minority | ||
| Tech and Biomedical Foundation | Venture Capital | Minority | ||
| EIT Health | Accelerator/Incubator |
RECORNEA FAQs
-
When was RECORNEA founded?
RECORNEA was founded in 2019.
-
Where is RECORNEA headquartered?
RECORNEA is headquartered in Trieste, Italy.
-
What is the size of RECORNEA?
RECORNEA has 6 total employees.
-
What industry is RECORNEA in?
RECORNEA’s primary industry is Therapeutic Devices.
-
Is RECORNEA a private or public company?
RECORNEA is a Private company.
-
What is RECORNEA’s current revenue?
The current revenue for RECORNEA is .
-
How much funding has RECORNEA raised over time?
RECORNEA has raised $19.6M.
-
Who are RECORNEA’s investors?
Caique Holding, DN Lemans, Scientifica, Tech and Biomedical Foundation, and EIT Health are 5 of 12 investors who have invested in RECORNEA.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process